Target intelligence / Profile preview

Achaete-scute family bHLH transcription factor 5 (ASCL5)

Target
ASCL5
Molecular classification
Transcription factor, Basic helix-loop-helix protein
01

Overview

Achaete-scute family bHLH transcription factor 5 (ASCL5) is a member of the achaete-scute complex-like family of basic helix-loop-helix transcription factors. It is a DNA-binding transcription factor predicted to regulate transcription by RNA polymerase II, possibly through sequence-specific binding to E-box motifs in cooperation with other factors such as TCF3/E12. ASCL5 negatively modulates the expression of certain genes, including CDH1/E-cadherin, likely by recruiting the PRC2 repressive chromatin complex to regulatory elements. It plays roles in ameloblast development, tooth germ growth, and enamel formation. While data on ASCL5 remain limited, bioinformatics and gene expression analyses suggest altered expression patterns in cancer: it is upregulated in some lung cancers and downregulated in several brain tumors, implicating a possible role in tumor biology. ASCL5 is part of the broader ASCL transcription factor family, which is critical for development of the nervous system and implicated in progenitor cell biology, injury response, and possibly oncogenesis[1][4][6].

Other names
BHLHA47ASH-5hASH5bHLHa47AmeloDachaete-scute homolog 5achaete-scute complex homolog 5class A basic helix-loop-helix protein 47
02

Biological functions

Regulation of DNA-templated transcriptionNegative modulation of transcription of target genes (e.g., CDH1/E-cadherin)Chromatin bindingRNA polymerase II regulatory region sequence-specific DNA bindingRegulation of ameloblast development and tooth germ growthEnamel formation
03

Disease associations

Cancer (implicated in tumor onset/progression, e.g. lung cancer, brain tumors)Abnormalities of tooth development (e.g., amelodentinogenesis)

Beyond the preview

Go deeper on Achaete-scute family bHLH transcription factor 5 (ASCL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Achaete-scute family bHLH transcription factor 5 (ASCL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call